We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02009592
Recruitment Status : Completed
First Posted : December 12, 2013
Last Update Posted : May 16, 2014
Information provided by (Responsible Party):
Bezmialem Vakif University